UNAUDITED QUARTERLY DATA | NAUDITED QUARTERLY DATA Three months ended ($ in thousands, except per share data) September 30, 2018 December 31, 2018 March 31, 2019 June 30, 2019 (unaudited) (unaudited) (unaudited) (unaudited) Revenue $ 33,522 $ 34,406 $ 37,646 $ 38,225 Gross profit $ 10,110 $ 9,243 $ 9,779 $ 8,987 Operating loss $ (5,921 ) $ (10,200 ) $ (3,892 ) $ (10,143 ) Net loss $ (6,320 ) $ (10,657 ) $ (4,510 ) $ (10,541 ) Cumulative preferred dividends $ (334 ) $ — $ (334 ) $ — Net loss applicable to common shares $ (6,654 ) $ (10,657 ) $ (4,844 ) $ (10,541 ) Net loss per common share - basic $ (0.11 ) $ (0.18 ) $ (0.08 ) $ (0.18 ) Net loss per common share - diluted $ (0.11 ) $ (0.18 ) $ (0.08 ) $ (0.18 ) Weighted average number of common shares outstanding - basic 60,053,912 60,059,936 60,065,053 60,065,978 Weighted average number of common shares outstanding - diluted 60,053,912 60,059,936 60,065,053 60,065,978 Three months ended ($ in thousands, except per share data) September 30, 2017 December 31, 2017 March 31, 2018 June 30, 2018 (unaudited) (unaudited) (unaudited) (unaudited) Revenue $ 25,259 $ 31,532 $ 33,592 $ 42,125 Gross profit $ 6,181 $ 9,172 $ 9,845 $ 10,478 Operating loss $ (1,750 ) $ (3,905 ) $ (2,566 ) $ (1,002 ) Net loss $ (2,171 ) $ (4,194 ) $ (3,223 ) $ (1,696 ) Cumulative preferred dividends $ (334 ) $ — $ (334 ) $ — Net loss applicable to common shares $ (2,505 ) $ (4,194 ) $ (3,557 ) $ (1,696 ) Net loss per common share - basic $ (0.05 ) $ (0.08 ) $ (0.07 ) $ (0.03 ) Net loss per common share - diluted $ (0.05 ) $ (0.08 ) $ (0.07 ) $ (0.03 ) Weighted average number of common shares outstanding - basic 47,573,364 52,150,106 53,637,085 54,064,750 Weighted average number of common shares outstanding - diluted 47,573,364 52,150,106 53,637,085 54,064,750 Three months ended ($ in thousands, except per share data) September 30, 2016 December 31, 2016 March 31, 2017 June 30, 2017 (unaudited) (unaudited) (unaudited) (unaudited) Revenue $ 21,569 $ 21,787 $ 26,301 $ 31,779 Gross profit $ 6,297 $ 6,445 $ 6,342 $ 5,977 Operating loss $ (1,383 ) $ 109 $ (459 ) $ (2,401 ) Net loss $ (3,370 ) $ (232 ) $ (925 ) $ (2,938 ) Cumulative preferred dividends $ (334 ) $ — $ (334 ) $ — Net loss applicable to common shares $ (3,704 ) $ (232 ) $ (1,259 ) $ (2,938 ) Net loss per common share - basic $ (0.10 ) $ (0.01 ) $ (0.03 ) $ (0.07 ) Net loss per common share - diluted $ (0.10 ) $ (0.01 ) $ (0.03 ) $ (0.07 ) Weighted average number of common shares outstanding - basic 38,488,005 40,308,934 40,327,697 40,331,993 Weighted average number of common shares outstanding - diluted 38,488,005 40,308,934 40,327,697 40,331,993 Explanatory Note: Th e Company is providing restated quarterly and year-to-date unaudited consolidated financial information for interim periods occurring within fiscal years ended June 30, 2017 and 2018 in order to comply with SEC requirements. Refer to Note 2 — "Restatement of Consolidated Financial Statements" for further background concerning the events preceding the restatement of financial information in this Form 10-K/A. As discussed in Note 2 , the Audit Committee and the Company identified certain errors that are corrected through adjustments made as part of the restatement. These adjustments include corrections related to the investigation of customer transactions that was conducted, as well as (i) corrections related to the Company's acquisition and financial integration of Cantaloupe and (ii) corrections resulting from management's review of significant accounts and transactions. A summary of the impact of these matters on income (loss) before taxes is presented below: ($ in thousands) Increase / (Decrease) Restatement Impact Three months ended September 30, 2017 Three months ended December 31, 2017 Six months ended December 31, 2017 Three months ended March 31, 2018 Nine months ended March 31, 2018 Audit Committee Investigation-related Adjustments: Revenue $ (411 ) $ (866 ) $ (1,277 ) $ (768 ) $ (2,045 ) Costs of sales $ 165 $ (1,225 ) $ (1,060 ) $ (293 ) $ (1,353 ) Gross profit $ (576 ) $ 359 $ (217 ) $ (475 ) $ (692 ) Operating income (loss) $ (576 ) $ 359 $ (217 ) $ (9 ) $ (226 ) Income (loss) before income taxes $ (576 ) $ 357 $ (219 ) $ (29 ) $ (248 ) Acquisition and Financial Integration-related Adjustments: Revenue $ — $ (60 ) $ (60 ) $ (1,546 ) $ (1,606 ) Costs of sales $ — $ (33 ) $ (33 ) $ (79 ) $ (112 ) Gross profit $ — $ (27 ) $ (27 ) $ (1,467 ) $ (1,494 ) Operating income (loss) $ — $ (288 ) $ (288 ) $ (1,594 ) $ (1,882 ) Income (loss) before income taxes $ — $ (223 ) $ (223 ) $ (1,499 ) $ (1,722 ) Significant Account and Transaction Review and Other: Revenue $ 53 $ (47 ) $ 6 $ 75 $ 81 Costs of sales $ 497 $ 313 $ 810 $ 231 $ 1,041 Gross profit $ (444 ) $ (360 ) $ (804 ) $ (156 ) $ (960 ) Operating income (loss) $ (622 ) $ (775 ) $ (1,397 ) $ (461 ) $ (1,858 ) Income (loss) before income taxes $ (886 ) $ (1,041 ) $ (1,927 ) $ (696 ) $ (2,623 ) ($ in thousands) Increase / (Decrease) Restatement Impact Three months ended September 30, 2016 Three months ended December 31, 2016 Six months ended December 31, 2016 Three months ended March 31, 2017 Nine months ended March 31, 2017 Three months ended June 30, 2017 Audit Committee Investigation-related Adjustments: Revenue $ — $ — $ — $ (111 ) $ (111 ) $ (2,457 ) Costs of sales $ — $ — $ — $ (24 ) $ (24 ) $ (1,139 ) Gross profit $ — $ — $ — $ (87 ) $ (87 ) $ (1,318 ) Operating income (loss) $ — $ — $ — $ (87 ) $ (87 ) $ (1,318 ) Income (loss) before income taxes $ — $ — $ — $ (87 ) $ (87 ) $ (1,318 ) Significant Account and Transaction Review and Other: Revenue $ (18 ) $ 31 $ 13 $ (49 ) $ (36 ) $ (53 ) Costs of sales $ (148 ) $ (81 ) $ (229 ) $ 147 $ (82 ) $ 173 Gross profit $ 130 $ 112 $ 242 $ (196 ) $ 46 $ (226 ) Operating income (loss) $ (434 ) $ (124 ) $ (558 ) $ (790 ) $ (1,348 ) $ (1,516 ) Income (loss) before income taxes $ (769 ) $ (441 ) $ (1,210 ) $ (1,159 ) $ (2,369 ) $ (1,831 ) A summary of the impact of these matters on the consolidated balance sheet is presented below, excluding any tax effect from the restatement adjustments in the aggregate: ($ in thousands) Increase / (Decrease) Restatement Impact As of September 30, 2016 As of December 31, 2016 As of March 31, 2017 As of September 30, 2017 As of December 31, 2017 As of March 31, 2018 Audit Committee Investigation-related Adjustments: Accounts receivables $ — $ — $ — $ (315 ) $ (1,774 ) $ (1,954 ) Finance receivables, net $ — $ — $ 92 $ (1,640 ) $ (1,269 ) $ (1,666 ) Inventory, net $ — $ — $ — $ 941 $ 2,166 $ 2,459 Prepaid expenses and other current assets $ — $ — $ 30 $ 25 $ 25 $ 25 Other assets $ — $ — $ 95 $ 82 $ 76 $ 69 Property and equipment, net $ — $ — $ — $ — $ (162 ) $ (146 ) Accounts payable $ — $ — $ 270 $ 270 $ 106 $ 99 Accrued expenses $ — $ — $ 34 $ 803 $ 580 $ 341 Acquisition and Financial Integration-related Adjustments: Cash and cash equivalents $ — $ — $ — $ — $ (26 ) $ (52 ) Accounts receivables $ — $ — $ — $ — $ 1,133 $ (1,974 ) Finance receivables, net $ — $ — $ — $ — $ (1,515 ) $ 158 Inventory, net $ — $ — $ — $ — $ (500 ) $ (500 ) Prepaid expenses and other current assets $ — $ — $ — $ — $ (35 ) $ (44 ) Property and equipment, net $ — $ — $ — $ — $ 721 $ 826 Other assets $ — $ — $ — $ — $ (139 ) $ (175 ) Goodwill $ — $ — $ — $ — $ 4,121 $ 4,121 Accrued expenses $ — $ — $ — $ — $ 785 $ 883 Deferred revenue $ — $ — $ — $ — $ (153 ) $ (153 ) Common stock $ — $ — $ — $ — $ 3,469 $ 3,469 Significant Account and Transaction Review and Other: Accounts receivables $ (143 ) $ 110 $ 61 $ 77 $ (8 ) $ 127 Finance receivables, net $ — $ — $ — $ — $ 1,074 $ 28 Inventory, net $ (338 ) $ (348 ) $ (470 ) $ (305 ) $ (861 ) $ (1,067 ) Prepaid expenses and other current assets $ 13 $ 13 $ 13 $ (136 ) $ (150 ) $ (173 ) Other assets $ — $ — $ — $ (543 ) $ (600 ) $ (693 ) Property and equipment, net $ 2,865 $ 2,561 $ 2,168 $ (1,149 ) $ (737 ) $ (635 ) Accounts payable $ 17 $ 19 $ 21 $ 25 $ 27 $ 29 Accrued expenses $ 4,506 $ 5,222 $ 6,166 $ 8,319 $ 9,087 $ 9,877 Line of credit, net $ 13 $ 13 $ 13 $ — $ — $ — Capital lease obligation and current obligations under long-term debt $ 4,117 $ 3,566 $ 2,998 $ (21 ) $ 367 $ (5 ) Deferred revenue $ — $ — $ — $ (27 ) $ (27 ) $ (27 ) Deferred gain from sale-leaseback transactions $ (685 ) $ (470 ) $ (255 ) $ (198 ) $ (198 ) $ (198 ) Deferred gain from sale-leaseback transactions, less current portion $ — $ — $ — $ (99 ) $ (49 ) $ — Capital lease obligation and long-term debt, less current portion $ — $ — $ — $ — $ 697 $ — Common stock $ — $ — $ — $ (166 ) $ (372 ) $ (867 ) The effect of the restatement on the previously filed consolidated balance sheet as of September 30, 2017 is as follows: As of September 30, 2017 ($ in thousands, except per share data) As Previously Reported Adjustments As Restated Assets Current assets: Cash and cash equivalents $ 51,870 $ — $ 51,870 Accounts receivable 10,288 (473 ) 9,815 Finance receivables, net 3,082 (1,641 ) 1,441 Inventory, net 8,240 636 8,876 Prepaid expenses and other current assets 1,122 (66 ) 1,056 Total current assets 74,602 (1,544 ) 73,058 Non-current assets: Finance receivables due after one year 7,742 — 7,742 Other assets 750 (461 ) 289 Property and equipment, net 11,850 (1,149 ) 10,701 Deferred income taxes 28,205 (28,205 ) — Intangibles, net 578 — 578 Goodwill 11,492 — 11,492 Total non-current assets 60,617 (29,815 ) 30,802 Total assets $ 135,219 $ (31,359 ) $ 103,860 Liabilities, convertible preferred stock and shareholders’ equity Current liabilities: Accounts payable $ 14,211 $ 295 $ 14,506 Accrued expenses 3,795 8,422 12,217 Line of credit, net 7,051 — 7,051 Capital lease obligations and current obligations under long-term debt 2,649 (21 ) 2,628 Income taxes payable 10 (10 ) — Deferred revenue — 439 439 Deferred gain from sale-leaseback transactions 197 (197 ) — Total current liabilities 27,913 8,928 36,841 Long-term liabilities: Deferred income taxes — 109 109 Capital lease obligations and long-term debt, less current portion 1,049 — 1,049 Accrued expenses, less current portion 62 — 62 Deferred gain from sale-leaseback transactions, less current portion 99 (99 ) — Total long-term liabilities 1,210 10 1,220 Total liabilities $ 29,123 $ 8,938 $ 38,061 Commitments and contingencies Convertible preferred stock: Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,109 at September 30, 2017 — 3,138 3,138 Shareholders’ equity: Preferred stock, no par value, 1,800,000 shares authorized, no shares issued — — — Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,109 at September 30, 2017 3,138 (3,138 ) — Common stock, no par value, 640,000,000 shares authorized, 50,194,731 shares issued and outstanding at September 30, 2017 286,463 (167 ) 286,296 Accumulated deficit (183,505 ) (40,130 ) (223,635 ) Total shareholders’ equity 106,096 (43,435 ) 62,661 Total liabilities, convertible preferred stock and shareholders’ equity $ 135,219 $ (31,359 ) $ 103,860 The effect of the restatement on the previously filed consolidated statement of operations for the three months ended September 30, 2017 is as follows: Three months ended September 30, 2017 ($ in thousands, except per share data) As Previously Reported Adjustments As Restated Revenue: License and transaction fees $ 19,944 $ (547 ) $ 19,397 Equipment sales 5,673 189 5,862 Total revenue 25,617 (358 ) 25,259 Costs of sales: Cost of services 13,326 (79 ) 13,247 Cost of equipment 5,090 741 5,831 Total costs of sales 18,416 662 19,078 Gross profit 7,201 (1,020 ) 6,181 Operating expenses: Selling, general and administrative 6,746 178 6,924 Integration and acquisition costs 762 — 762 Depreciation and amortization 245 — 245 Total operating expenses 7,753 178 7,931 Operating loss (552 ) (1,198 ) (1,750 ) Other income (expense): Interest income 80 — 80 Interest expense (209 ) (264 ) (473 ) Total other expense, net (129 ) (264 ) (393 ) Loss before income taxes (681 ) (1,462 ) (2,143 ) Benefit (provision) for income taxes 468 (496 ) (28 ) Net loss (213 ) (1,958 ) (2,171 ) Preferred dividends (334 ) — (334 ) Net loss applicable to common shares $ (547 ) $ (1,958 ) $ (2,505 ) Net loss per common share Basic $ (0.01 ) $ (0.04 ) $ (0.05 ) Diluted $ (0.01 ) $ (0.04 ) $ (0.05 ) Weighted average number of common shares outstanding Basic 47,573,364 — 47,573,364 Diluted 47,573,364 — 47,573,364 The effect of the restatement on the previously filed consolidated statement of cash flows for the three months ended September 30, 2017 is as follows: Three months ended September 30, 2017 ($ in thousands) As Previously Reported Adjustments As Restated OPERATING ACTIVITIES: Net loss $ (213 ) $ (1,958 ) $ (2,171 ) Adjustments to reconcile net loss to net cash provided by operating activities: Non-cash stock-based compensation 576 (167 ) 409 (Gain) loss on disposal of property and equipment (18 ) — (18 ) Non-cash interest and amortization of debt discount 15 2 17 Bad debt expense 118 50 168 Provision for inventory reserve — 221 221 Depreciation and amortization 1,492 (122 ) 1,370 Excess tax benefits 67 — 67 Deferred income taxes, net (535 ) 551 16 Recognition of deferred gain from sale-leaseback transactions (43 ) 43 — Changes in operating assets and liabilities: Accounts receivable (3,192 ) 43 (3,149 ) Finance receivables, net 8,771 397 9,168 Inventory, net (3,648 ) (252 ) (3,900 ) Prepaid expenses and other current assets (217 ) 114 (103 ) Accounts payable and accrued expenses (2,168 ) 678 (1,490 ) Deferred revenue — 171 171 Income taxes payable — (55 ) (55 ) Net cash provided by operating activities 1,005 (284 ) 721 INVESTING ACTIVITIES: Purchase of property and equipment, including rentals (992 ) 272 (720 ) Proceeds from sale of property and equipment 45 — 45 Net cash used in investing activities (947 ) 272 (675 ) FINANCING ACTIVITIES: Issuance of common stock in public offering, net 39,888 — 39,888 Repayment of capital lease obligations and long-term debt (821 ) 12 (809 ) Net cash provided by financing activities 39,067 12 39,079 Net increase in cash and cash equivalents 39,125 — 39,125 Cash and cash equivalents at beginning of year 12,745 — 12,745 Cash and cash equivalents at end of period $ 51,870 $ — $ 51,870 The effect of the restatement on the previously filed consolidated balance sheet as of December 31, 2017 is as follows: As of December 31, 2017 ($ in thousands, except per share data) As Previously Reported Adjustments As Restated Assets Current assets: Cash and cash equivalents $ 15,386 $ (26 ) $ 15,360 Accounts receivable 15,472 (765 ) 14,707 Finance receivables, net 5,517 (2,221 ) 3,296 Inventory, net 11,215 804 12,019 Prepaid expenses and other current assets 1,971 (361 ) 1,610 Total current assets 49,561 (2,569 ) 46,992 Non-current assets: Finance receivables due after one year 11,215 513 11,728 Other assets 1,120 (662 ) 458 Property and equipment, net 12,622 (179 ) 12,443 Deferred income taxes 14,774 (14,774 ) — Intangibles, net 30,910 — 30,910 Goodwill 64,449 (46 ) 64,403 Total non-current assets 135,090 (15,148 ) 119,942 Total assets $ 184,651 $ (17,717 ) $ 166,934 Liabilities, convertible preferred stock and shareholders’ equity Current liabilities: Accounts payable $ 23,775 $ 133 $ 23,908 Accrued expenses 6,798 9,825 16,623 Capital lease obligations, current obligations under long-term debt, and collateralized borrowings 5,121 367 5,488 Income taxes payable 6 (6 ) — Deferred revenue 595 135 730 Deferred gain from sale-leaseback transactions 198 (198 ) — Total current liabilities 36,493 10,256 46,749 Long-term liabilities: Revolving credit facility 10,000 — 10,000 Deferred income taxes — 91 91 Capital lease obligations, long-term debt, and collateralized borrowings, less current portion 23,874 696 24,570 Accrued expenses, less current portion 65 — 65 Deferred gain from sale-leaseback transactions, less current portion 49 (49 ) — Total long-term liabilities 33,988 738 34,726 Total liabilities $ 70,481 $ 10,994 $ 81,475 Commitments and contingencies Convertible preferred stock: Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,109 at December 31, 2017 — 3,138 3,138 Shareholders’ equity: Preferred stock, no par value, 1,800,000 shares authorized, no shares issued — — — Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,109 at December 31, 2017 3,138 (3,138 ) — Common stock, no par value, 640,000,000 shares authorized, 53,619,898 shares issued and outstanding at December 31, 2017 307,053 3,097 310,150 Accumulated deficit (196,021 ) (31,808 ) (227,829 ) Total shareholders’ equity 114,170 (31,849 ) 82,321 Total liabilities, convertible preferred stock and shareholders’ equity $ 184,651 $ (17,717 ) $ 166,934 The effect of the restatement on the previously filed consolidated statement of operations for the three and six months ended December 31, 2017 is as follows: Three months ended December 31, 2017 Six months ended December 31, 2017 ($ in thousands, except per share data) As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated Revenue: License and transaction fees $ 22,853 $ 661 $ 23,514 $ 42,797 $ 114 $ 42,911 Equipment sales 9,653 (1,635 ) 8,018 15,326 (1,446 ) 13,880 Total revenue 32,506 (974 ) 31,532 58,123 (1,332 ) 56,791 Costs of sales: Cost of services 14,362 (6 ) 14,356 27,688 (85 ) 27,603 Cost of equipment 8,943 (939 ) 8,004 14,033 (198 ) 13,835 Total costs of sales 23,305 (945 ) 22,360 41,721 (283 ) 41,438 Gross profit 9,201 (29 ) 9,172 16,402 (1,049 ) 15,353 Operating expenses: Selling, general and administrative 8,329 676 9,005 15,075 854 15,929 Integration and acquisition costs 3,335 — 3,335 4,097 — 4,097 Depreciation and amortization 737 — 737 982 — 982 Total operating expenses 12,401 676 13,077 20,154 854 21,008 Operating loss (3,200 ) (705 ) (3,905 ) (3,752 ) (1,903 ) (5,655 ) Other income (expense): Interest income 251 73 324 331 73 404 Interest expense (494 ) (276 ) (770 ) (703 ) (540 ) (1,243 ) Total other expense, net (243 ) (203 ) (446 ) (372 ) (467 ) (839 ) Loss before income taxes (3,443 ) (908 ) (4,351 ) (4,124 ) (2,370 ) (6,494 ) (Provision) benefit for income taxes (9,073 ) 9,230 157 (8,605 ) 8,734 129 Net loss (12,516 ) 8,322 (4,194 ) (12,729 ) 6,364 (6,365 ) Preferred dividends — — — (334 ) — (334 ) Net loss applicable to common shares $ (12,516 ) $ 8,322 $ (4,194 ) $ (13,063 ) $ 6,364 $ (6,699 ) Net loss per common share Basic $ (0.24 ) $ 0.16 $ (0.08 ) $ (0.26 ) $ 0.13 $ (0.13 ) Diluted $ (0.24 ) $ 0.16 $ (0.08 ) $ (0.26 ) $ 0.13 $ (0.13 ) Weighted average number of common shares outstanding Basic 52,150,106 — 52,150,106 49,861,735 — 49,861,735 Diluted 52,150,106 — 52,150,106 49,861,735 — 49,861,735 The effect of the restatement on the previously filed consolidated statement of cash flows for the six months ended December 31, 2017 is as follows: Six months ended December 31, 2017 ($ in thousands) As Previously Reported Adjustments As Restated OPERATING ACTIVITIES: Net loss $ (12,729 ) $ 6,364 $ (6,365 ) Adjustments to reconcile net loss to net cash provided by operating activities: Non-cash stock-based compensation 1,356 (372 ) 984 (Gain) loss on disposal of property and equipment (83 ) 3 (80 ) Non-cash interest and amortization of debt discount 86 8 94 Bad debt expense 291 91 382 Provision for inventory reserve — 1,091 1,091 Depreciation and amortization 3,476 (198 ) 3,278 Excess tax benefits 67 — 67 Deferred income taxes, net 8,537 (8,696 ) (159 ) Recognition of deferred gain from sale-leaseback transactions (93 ) 93 — Changes in operating assets and liabilities: Accounts receivable (5,290 ) (42 ) (5,332 ) Finance receivables, net 7,958 (626 ) 7,332 Inventory, net (5,822 ) (1,793 ) (7,615 ) Prepaid expenses and other current assets (606 ) 604 (2 ) Accounts payable and accrued expenses 6,950 754 7,704 Deferred revenue — 570 570 Income taxes payable 40 (80 ) (40 ) Net cash provided by operating activities 4,138 (2,229 ) 1,909 INVESTING ACTIVITIES: Purchase of property and equipment, including rentals (1,767 ) 33 (1,734 ) Proceeds from sale of property and equipment 157 — 157 Cash paid for acquisitions, net of cash acquired (65,181 ) — (65,181 ) Net cash used in investing activities (66,791 ) 33 (66,758 ) FINANCING ACTIVITIES: Proceeds from collateralized borrowing from the transfer of finance receivables — 1,075 1,075 Payment of debt issuance costs (445 ) — (445 ) Proceeds from issuance of long-term debt 25,100 — 25,100 Proceeds from revolving credit facility 10,000 — 10,000 Issuance of common stock in public offering, net 39,888 — 39,888 Repayment of line of credit (7,111 ) — (7,111 ) Repayment of capital lease obligations and long-term debt (2,138 ) 1,095 (1,043 ) Net cash provided by financing activities 65,294 2,170 67,464 Net increase in cash and cash equivalents 2,641 (26 ) 2,615 Cash and cash equivalents at beginning of year 12,745 — 12,745 Cash and cash equivalents at end of period $ 15,386 $ (26 ) $ 15,360 The effect of the restatement on the previously filed consolidated balance sheet as of March 31, 2018 is as follows: As of March 31, 2018 ($ in thousands, except per share data) As Previously Reported Adjustments As Restated Assets Current assets: Cash and cash equivalents $ 17,107 $ (52 ) $ 17,055 Accounts receivable 23,166 (3,723 ) 19,443 Finance receivables, net 3,904 (1,670 ) 2,234 Inventory, net 11,030 893 11,923 Prepaid expenses and other current assets 1,869 (591 ) 1,278 Total current assets 57,076 (5,143 ) 51,933 Non-current assets: Finance receivables due after one year 9,679 191 9,870 Other assets 1,214 (800 ) 414 Property and equipment, net 12,198 45 12,243 Deferred income taxes 16,911 (16,911 ) — Intangibles, net 30,119 — 30,119 Goodwill 64,196 (47 ) 64,149 Total non-current assets 134,317 (17,522 ) 116,795 Total assets $ 191,393 $ (22,665 ) $ 168,728 Liabilities, convertible preferred stock and shareholders’ equity Current liabilities: Accounts payable $ 29,446 $ 128 $ 29,574 Accrued expenses 7,961 10,547 18,508 Capital lease obligations and current obligations under long-term debt 4,475 (5 ) 4,470 Deferred revenue 441 70 511 Deferred gain from sale-leaseback transactions 198 (198 ) — Total current liabilities 42,521 10,542 53,063 Long-term liabilities: Revolving credit facility 10,000 — 10,000 Deferred income taxes — 96 96 Capital lease obligations and long-term debt, less current portion 22,895 — 22,895 Accrued expenses, less current portion 66 — 66 Total long-term liabilities 32,961 96 33,057 Total liabilities $ 75,482 $ 10,638 $ 86,120 Commitments and contingencies Convertible preferred stock: Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,443 at March 31, 2018 — 3,138 3,138 Shareholders’ equity: Preferred stock, no par value, 1,800,000 shares authorized, no shares issued — — — Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $19,443 at March 31, 2018 3,138 (3,138 ) — Common stock, no par value, 640,000,000 shares authorized, 53,666,718 shares issued and outstanding at March 31, 2018 307,634 2,888 310,522 Accumulated deficit (194,861 ) (36,191 ) (231,052 ) Total shareholders’ equity 115,911 (36,441 ) 79,470 Total liabilities, convertible preferred stock and shareholders’ equity $ 191,393 $ (22,665 ) $ 168,728 The effect of the restatement on the previously filed consolidated statement of operations for the three and nine months ended March 31, 2018 is as follows: Three months ended March 31, 2018 Nine months ended March 31, 2018 ($ in thousands, except per share data) As Previously Reported Adjustments As Restated As Previously Reported Adjustments As Restated Revenue: License and transaction fees $ 27,020 $ (1,639 ) $ 25,381 $ 69,817 $ (1,525 ) $ 68,292 Equipment sales 8,812 (601 ) 8,211 24,138 (2,047 ) 22,091 Total revenue 35,832 (2,240 ) 33,592 93,955 (3,572 ) 90,383 Costs of sales: Cost of services 16,012 25 16,037 43,700 (60 ) 43,640 Cost of equipment 7,876 (166 ) 7,710 21,909 (364 ) 21,545 Total costs of sales 23,888 (141 ) 23,747 65,609 (424 ) 65,185 Gross profit 11,944 (2,099 ) 9,845 28,346 (3,148 ) 25,198 Operating expenses: Selling, general and administrative 9,572 57 9,629 24,647 911 25,558 Integration and acquisition costs 1,747 (70 ) 1,677 5,844 (70 ) 5,774 Depreciation and amortization 1,125 (20 ) 1,105 2,107 (20 ) 2,087 Total operating expenses 12,444 (33 ) 12,411 32,598 821 33,419 Operating loss (500 ) (2,066 ) (2,566 ) (4,252 ) (3,969 ) (8,221 ) Other income (expense): Interest income 134 92 226 465 165 630 Interest expense (612 ) (251 ) (863 ) (1,315 ) (791 ) (2,106 ) Total other expense, net (478 ) (159 ) (637 ) (850 ) (626 ) (1,476 ) Loss before income taxes (978 ) (2,225 ) (3,203 ) (5,102 ) (4,595 ) (9,697 ) Benefit (provision) for income taxes 2,138 (2,158 ) (20 ) (6,467 ) 6,576 109 Net income (loss) 1,160 (4,383 ) (3,223 ) (11,569 ) 1,981 (9,588 ) Preferred dividends (334 ) — (334 ) (668 ) — (668 ) Net income (loss) applicable to common shares $ 826 $ (4,383 ) $ (3,557 ) $ (12,237 ) $ 1,981 $ (10,256 ) Net income (loss) per common share Basic $ 0.02 $ (0.09 ) $ (0.07 ) $ (0.24 ) $ 0.04 $ (0.20 ) Diluted $ 0.02 $ (0.09 ) $ (0.07 ) $ (0.24 ) $ 0.04 $ (0.20 ) Weighted average number of common shares outstanding Basic 53,637,085 — 53,637,085 51,101,813 — 51,101,813 Diluted 54,234,566 (597,481 ) 53,637,085 51,101,813 — 51,101,813 The effect of the restatement on the previously filed consolidated statement of cash flows for the nine months ended March 31, 2018 is as follows: Nine months ended March 31, 2018 ($ in thousands) As Previously Reported Adjustments As Restated OPERATING ACTIVITIES: Net loss $ (11,569 ) $ 1,981 $ (9,588 ) Adjustments to reconcile net loss to net cash provided by operating activities: Non-cash stock-based compensation 2,005 (581 ) 1,424 (Gain) loss on disposal of property and equipment (112 ) 13 (99 ) Non-cash interest and amortization of debt discount 100 18 118 Bad debt expense 506 4 510 Provision for inventory reserve — 1,361 1,361 Depreciation and amortization 5,858 (272 ) 5,586 Excess tax benefits 67 — 67 Deferred income taxes, net 6,400 (6,554 ) (154 ) Recognition of deferred gain from sale-leaseback transactions (143 ) 143 — Changes in operating assets and liabilities: Accounts receivable (12,972 ) 3,008 (9,964 ) Finance receivables, net 11,114 (2,912 ) 8,202 Sale of finance receivables — 2,051 2,051 Inventory, net (5,624 ) (2,153 ) (7,777 ) Prepaid expenses and other current assets (564 ) 919 355 Accounts payable and accrued expenses 13,808 1,447 15,255 Deferred revenue (185 ) 536 351 Income taxes payable — (30 ) (30 ) Net cash provided by operating activities 8,689 (1,021 ) 7,668 INVESTING ACTIVITIES: Purchase of property and equipment, including rentals (3,005 ) (133 ) (3,138 ) Proceeds from sale of property and equipment 252 — 252 Cash paid for acquisitions, net of cash acquired (65,181 ) — (65,181 ) Net cash used in investing activities (67,934 ) (133 ) (68,067 ) FINANCING ACTIVITIES: Proceeds from collateralized borrowing from the transfer of finance receivables — 1,075 1,075 Cash used in retirement of common stock (156 ) — (156 ) Proceeds from exercise of common stock options 109 — 109 Payment of debt issuance costs (445 ) — (445 ) Proceeds from issuance of long-term debt 25,100 — 25,100 Proceeds from revolving credit facility 12,500 — 12,500 Repayment of revolving credit facility (2,500 ) — (2,500 ) Issuance of common stock in public offering, net 39,888 — 39,888 Repayment of line of credit (7,111 ) — (7,111 ) Repayment of capital lease obligations and long-term debt (3,778 ) 27 (3,751 ) Net cash provided by financing activities 63,607 1,102 64,709 Net increase in cash and cash equivalents 4,362 (52 ) 4,310 Cash and cash equivalents at beginning of year 12,745 — 12,745 Cash and cash equivalents at end of period $ 17,107 $ (52 ) $ 17,055 The effect of the restatement on the previously filed consolidated balance sheet as of September 30, 2016 is as follows: As of September 30, 2016 ($ in thousands, except per share data) As Previously Reported Adjustments As Restated Assets Current assets: Cash and cash equivalents $ 18,198 $ — $ 18,198 Accounts receivable 5,840 (233 ) 5,607 Finance receivables, net 3,349 — 3,349 Inventory, net 4,264 (338 ) 3,926 Prepaid expenses and other current assets 1,439 (87 ) 1,352 Deferred income taxes 2,271 (2,271 ) — Total current assets 35,361 (2,929 ) 32,432 Non-current assets: Finance receivables due after one year 3,962 — 3,962 Other assets 163 — 163 Property and equipment, net 9,570 2,866 12,436 Deferred income taxes 25,568 (25,568 ) — Intangibles, net 754 — 754 Goodwill 11,703 — 11,703 Total non-current assets 51,720 (22,702 ) 29,018 Total assets $ 87,081 $ (25,631 ) $ 61,450 Liabilities, convertible preferred stock and shareholders’ equity Current liabilities: Accounts payable $ 8,693 $ 17 $ 8,710 Accrued expenses 3,912 4,223 8,135 Line of credit, net 7,258 13 7,271 Capital lease obligations and current obligations under long-term debt 834 4,118 4,952 Income taxes payable 8 7 15 Deferred revenue — 94 94 Deferred gain from sale-leaseback transactions 685 (685 ) — Total current liabilities 21,390 7,787 29,177 Long-term liabilities: Deferred income tax — 47 47 Capital lease obligations and long-term debt, less current portion 1,517 — 1,517 Accrued expenses, less current portion 11 — 11 Total long-term liabilities 1,528 47 1,575 Total liabilities $ 22,918 $ 7,834 $ 30,752 Commitments and contingencies Convertible preferred stock: Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $18,442 at September 30, 2016 — 3,138 3,138 Shareholders’ equity: Preferred stock, no par value, 1,800,000 shares authorized, no shares issued — — — Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $18,442 at September 30, 2016 3,138 (3,138 ) — Common stock, no par value, 640,000,000 shares authorized, 40,295,425 shares issued and outstanding at September 30, 2016 244,996 — 244,996 Accumulated deficit (183,971 ) (33,465 ) (217,436 ) Total shareholders’ equity 64,163 (36,603 ) 27,560 Total liabilities, convertible preferred stock and shareholders’ equity $ 87,081 $ (25,631 ) $ 61,450 The effect of the restatement on the previously filed consolidated statement of operations for the three months ended September 30, 2016 is as follows: Three months ended September 30, 2016 ($ in thousands, except per share data) As Previously Reported Adjustments As Restated Revenue: License and transaction fees $ 16,365 $ (2 ) $ 16,363 Equipment sales 5,223 (17 ) 5,206 Total revenue 21,588 (19 ) 21,569 Costs of sales: Cost of services 11,243 (144 ) 11,099 Cost of equipment 4,178 (5 ) 4,173 Total costs of sales 15,421 (149 ) 15,272 Gross profit 6,167 130 6,297 Operating expenses: Selling, general and administrative 6,909 563 7,472 Depreciation and amortization 208 — 208 Total operating expenses 7,117 563 7,680 Operating loss (950 ) (433 ) (1,383 ) Other income (expense): Interest income 73 — 73 Interest expense (212 ) (335 ) (547 ) Change in fair value of warrant liabilities (1,490 ) — (1,490 ) Total other expense, net (1,629 ) (335 ) (1,964 ) Loss before income taxes (2,579 ) (768 ) (3,347 ) Benefit (provision) for income taxes 115 (138 ) (23 ) Net loss (2,464 ) (906 ) (3,370 ) Preferred dividends (334 ) — (334 ) Net loss applicable to common shares $ (2,798 ) $ (906 ) $ (3,704 ) Net loss per common share Basic $ (0.07 ) $ (0.03 ) $ (0.10 ) Diluted $ (0.07 ) $ (0.03 ) $ (0.10 ) Weighted average number of common shares outstanding Basic 38,488,005 — 38,488,005 Diluted 38,488,005 — 38,488,005 The effect of the restatement on the previously filed consolidated statement of cash flows for the three months ended September 30, 2016 is as follows: Three months ended September 30, 2016 ($ in thousands) As Previously Reported Adjustments As Restated OPERATING ACTIVITIES: Net loss $ (2,464 ) $ (906 ) $ (3,370 ) Adjustments to reconcile net loss to net cash used in operating activities: Non-cash stock-based compensation 211 — 211 Non-cash interest and amortization of debt discount 105 34 139 Bad debt expense 97 102 199 Provision for inventory reserve — 248 248 Depreciation and amortization 1,301 302 1,603 Change in fair value of warrant liab |